相关实验视频

Updated: Jul 27, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

阻断TRPM4抗体在延迟中风再输液中保护大脑血管

Bo Chen¹, Shunhui Wei¹, See Wee Low¹

¹Calcium Signalling Laboratory, Department of Research, National Neuroscience Institute, Singapore 308433, Singapore.

|May 27, 2023

概括

一种TRPM4阻断抗体,M4P,在延迟中风模型中降低了再注射损伤. 这种血管保护改善了结果,表明M4P可以增强中风治疗.

科学领域:

神经科学是一个神经科学.
心血管科学心血管科学
药理学药理学是指药理学的学科.

背景情况:

针对急性缺血性中风的再输血疗法恢复了血液流动,但可能导致血脑屏障破坏和再输血损伤.
延迟再注血会加剧损伤,导致大脑胀和出血转变.
在早期中风模型中,阻断TRPM4的抗体M4P显示出减轻逆流损伤的前途.

研究的目的:

为了研究TRPM4阻断抗体M4P在延迟中风再注射 (7小时封闭) 的老鼠模型中的疗效.
评估M4P在延迟再注血后对血管完整性,心脏病发作量,死亡率和功能结果的影响.

主要方法:

在大鼠中使用了7小时的中脑动脉封闭模型.
M4P或对照IgG在再输血前1小时被给予.
评估了血管形态,血管泄漏 (埃文斯蓝色外流),心脏病发作量,死亡率和Rotarod的性能.

主要成果:

M4P治疗改善了血管形态和减弱了中风后的血管泄漏.
提高血管完整性导致大脑输液的改善,心脏病发作的数量减少,死亡率降低.
由于对照组的高死亡率,在幸存的动物中没有观察到功能结果的显著差异.

结论:

阻断TRPM4的抗体M4P显示了在延迟中风再注射期间改善血管损伤的潜力.
当与中风的再流疗法相结合时,M4P可能提供一种治疗策略,以改善结果.

关键词:

抗体是一种抗体.缺氧缺氧是指缺氧的情况.中脑动脉封闭中脑动脉封闭模型模型模型模型模型模型保护保护保护保护转流伤害的伤害是因为再流.一次性中风中风中风中风中风治疗疗法治疗疗法治疗疗法暂时的受体潜在通道.血管血管血管血管

更多相关视频

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...